Silo Pharma, Inc. (NASDAQ:SILO – Get Free Report) saw a large increase in short interest in June. As of June 15th, there was short interest totalling 134,800 shares, an increase of 294.2% from the May 31st total of 34,200 shares. Based on an average trading volume of 254,000 shares, the days-to-cover ratio is presently 0.5 days. Currently, 4.0% of the company’s stock are short sold.
Silo Pharma Stock Performance
Shares of NASDAQ SILO remained flat at $0.97 on Friday. 52,056 shares of the company’s stock were exchanged, compared to its average volume of 186,804. The company has a 50 day moving average of $1.61 and a 200 day moving average of $1.63. Silo Pharma has a fifty-two week low of $0.91 and a fifty-two week high of $3.05.
Silo Pharma (NASDAQ:SILO – Get Free Report) last posted its quarterly earnings results on Monday, May 13th. The company reported ($0.28) earnings per share for the quarter. The company had revenue of $0.02 million during the quarter. Silo Pharma had a negative return on equity of 51.75% and a negative net margin of 4,992.30%.
About Silo Pharma
Silo Pharma. Inc, a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief.
Featured Stories
- Five stocks we like better than Silo Pharma
- What is Put Option Volume?
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- 3 Warren Buffett Stocks to Buy Now
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- What is the Nikkei 225 index?
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Silo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
